Home
About us
Technology platforms
Pipelines
News
Careers
Investors
Contact us
Biological insights driven cancer therapy
Cell:
BioTroy discovered the first ligand of CD3 as target for cancer immunotherapy
BioTroy Therapeutics is a biopharmaceutical company dedicated to the research and development of first-in-class therapies for the treatment of cancer and immunological disorders.
